TITLE:
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

CONDITION:
Post Menopausal Osteoporosis

INTERVENTION:
ibandronate [Bonviva/Boniva]

SUMMARY:

      This study will assess the efficacy and safety of intravenous administration of Bonviva
      regimens in women with post-menopausal osteoporosis, compared to oral daily administration.
      Patients will also receive daily supplementation with vitamin D and calcium. The anticipated
      time of study treatment is 2+ years, and the target sample size is 500+ individuals.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Female
Age: 55 Years to 80 Years
Criteria:

        Inclusion Criteria:

          -  women 55-80 years of age;

          -  post-menopausal for >=5 years;

          -  ambulatory.

        Exclusion Criteria:

          -  malignant disease diagnosed within the previous 10 years (except basal cell cancer
             that has been successfully removed);

          -  breast cancer within the previous 20 years;

          -  allergy to bisphosphonates;

          -  previous treatment with an intravenous bisphosphonate at any time;

          -  previous treatment with an oral bisphosphonate within the last 6 months, >1 month of
             treatment within the last year, or >3 months of treatment within the last 2 years.
      
